Homesfy Realty (HOMESFY)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 53.04% indicates significant insider alignment with shareholders.
• The business is asset-light real estate services, which can scale if the market recovers.
• Latest quarter sales of ₹20 crore provide some revenue base despite the loss.
• At ₹49 crore market cap, the stock trades at roughly 0.6 times annualised latest-quarter sales of ₹80 crore, offering cheapness only if a turnaround occurs.

Concerns

• Net loss of ₹8 crore on ₹20 crore sales implies a negative 40% net margin; P/E is meaningless.
• Sales growth of -34.68% and profit growth of -650.33% show severe operational deterioration.
• Piotroski F-Score of 3/9 and ROCE of only 4.80% indicate weak financial health and poor capital efficiency.
• No dividend and no disclosed book value leave no cushion for a margin of safety.

AI Analysis

Let me start with what I can see. Homesfy Realty sells at ₹154.35, a market cap of just ₹49 crore, but the latest quarter tells an alarming story: ₹20 crore in sales and a net loss of ₹8 crore. That is a 40% loss margin. When a company burns cash at this rate, I cannot call it an investment; it is a speculation. Sales have fallen 34.68%, and profit growth is minus 650.33%, meaning losses are widening, not narrowing. Graham would say price is what you pay, value is what you get. I cannot estimate value because book value and P/E are unavailable; with negative earnings, P/E is meaningless. The Piotroski F-score of 3/9 reinforces weak financial health. ROCE of 4.80% is far below what I require from a quality enterprise, and a zero dividend yield means the investor gets no cash while waiting. There is no obvious moat in real-estate related services; competition is intense and revenue is tied to the property cycle. The only comfort is promoter holding of 53.04%, which at least aligns owners with shareholders. But skin in the game doesn't compensate for a business losing 40% of every rupee of revenue. At 52-week low ₹100.95 and high ₹289.90, the stock is off its high, but in value investing, a declining price isn't a reason to buy; declining intrinsic value is. I need evidence that sales can stabilise, losses can shrink, and return on capital can move well above this 4.80%. Until then, this is a turnaround candidate, not a proven value proposition. My circle of competence says wait for better numbers.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer